12,115 followers
RT @FrontOncology: New research: Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes…
RT @FrontOncology: New research: Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes…
New research: Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis: Objectives Neoadjuvant chemoimmunotherapy is the optimal choice in the treatment of NSCLC;… #oncology https://